Co-founder Derek Small succeeds Russell H. Ellison, MD, as CEO, as had been agreed in the merger last year that established Assembly. Small remains President; current director William Ringo has been [...]
Developing a non-addictive painkiller to compete with opiates Mission Bay Capital portfolio company John Mulcahy is co-founder and vice-president of research at SiteOne Therapeutics, a company develo [...]
Improving human health by sequencing and analyzing the microbiome and developing targeted therapies Colleen Cutcliffe is co-founder and CEO of Whole Biome, a company working with the Mayo Clinic and o [...]
Targeting the hepatitis B virus Ramen to reverse merger in under two years. Uri Lopatin co-founded Assembly Pharmaceuticals in 2012, first working from home and then riding his bicycle to our incubato [...]
MedGenome is looking to partner with the state governments in the country to offer its OncoMD, a cancer analytics platform with information on over 1.2 million cancer mutations allowing accurate inter [...]
The FDA has published guidance to support the submission process for companies developing fixed-dose combinations (FDCs) for the treatment of HIV patients. According to this guidance, “FDCs are essent [...]
One of the lures of the University of California's QB3 incubator network for life sciences startups is access to the same core facilities — centralized sites with million-dollar pieces of equipment — [...]